Cadrenal Therapeutics Inc (CVKD) Live Share Price, Invest From India

Cadrenal Therapeutics Inc Stock Performance

as on April 10, 2026 at 6:54 am IST

Day's Low
Day's High
$4.66
Day's Price Range
$5.07
$4.86
4.12%
Downside
4.32%
Upside
52 Week's Low
52 Week's High
$4.21
52-Week Price Range
$17.50
$4.86
13.37%
Downside
260.08%
Upside

Cadrenal Therapeutics Inc share price movements today

Previous Close: $4.85
Open: $4.81
Volume: 90.6K
Day's Low - High: $4.66 - $5.07
52 Week Low - High: $4.21 - $17.50

Cadrenal Therapeutics Inc Historical Returns

1 Month Return: -39.38 %
3 Month Return: -40.64 %
1 Year Return: -67.67 %
3 Year Return: -77.55 %
5 Year Return: 0 %

Cadrenal Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cadrenal Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.8M

EPS (TTM)

-7.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-13.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-260.11%

Cadrenal Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cadrenal Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cadrenal Therapeutics Inc	BUY	$10.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.4B	136.74%	137.13	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$109.8B	108.07%	28.17	32.94%
Beone Medicines Ltd	NA	$34.9B	NA	124.01	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.4B	63.21%	18.32	31.41%

Stock Returns calculator for Cadrenal Therapeutics Inc Stock including INR - Dollar returns

The Cadrenal Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cadrenal Therapeutics Inc investment value today

Current value as on today

₹34,635

Returns

-₹65,365

(-65.37%)

Returns from Cadrenal Therapeutics Inc Stock

-₹67,600 (-67.6%)

Dollar Impact

₹2,235 (+2.23%)

Analyst Recommendation on Cadrenal Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cadrenal Therapeutics Inc. Average target price of $35

Cadrenal Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cadrenal Therapeutics Inc.

What analysts predicted

86.11%UPSIDE

Target Price

$35

Current Price

$4.86

Analyzed by

8 Analysts

Target

$35.00

Cadrenal Therapeutics Inc target price $35, a slight upside of 86.11% compared to current price of $4.86. According to 8 analysts rating.

Cadrenal Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Cadrenal Therapeutics Inc Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 11, 2026 to April 10, 2026

Change:-35% versus previous 30 day period

Cadrenal Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
EBITDA	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
Net Profit Margin	0.00%	-41331.65%	0.00%	0.00%	0.00%	-196216.92%	0.00%	0.00%	0.00%	0.00%

Cadrenal Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	0	0	-
Operating Income	-7	-10	-13
EBITDA	-8	-10	-13
Interest Expense	0	-	-
Depreciation	0	0	0
Income Before Tax	-8	-10	-13
Income Tax Expense	0	-	-
Net Income	-8	-10	-13
Net Profit Margin	0.00%	0.00%	0.00%

Cadrenal Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-1	-1	-2	-2	-4	-3	-3	-2	-3
Operating Cash Flow	0	-1	-1	-2	-1	-4	-3	-2	-2
Investing Cash Flow	-	-	-	-	0	0	0	0	0
Financing Cash Flow	0	0	-	1	7	1	1	0	2
Change in Cash	0	-1	-1	0	5	-2	-1	-1	0

Cadrenal Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-8	-10	-13
Operating Cash Flow	-3	-7	-12
Investing Cash Flow	0	0	0
Financing Cash Flow	11	8	6
Change in Cash	8	1	-6

Insights on Cadrenal Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 50.5% return, outperforming this stock by 115.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 111.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CVKD stock has moved down by -37.9%

About Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc. is a biopharmaceutical company developing therapeutics to overcome the limitations of anticoagulation therapy. It has three clinical-stage assets: VLX-1005, a first-in-class Phase 2 12-LOX Inhibitor for patients with HIT; tecarfarin, an oral vitamin K antagonist (VKA) for chronic use in patients with kidney dysfunction or left ventricular assist devices (LVADs), and frunexian, a parenteral small-molecule Factor XIa antagonist for use in acute hospital settings. Its product candidate, tecarfarin, is a late-stage, reversible oral VKA in the same drug class as warfarin, designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Its frunexian is a small molecule fast-on, fast-off parenteral Phase II-ready potent intravenous (IV) Factor XIa inhibitor designed for acute care settings, especially where contact activation of coagulation by medical devices or artificial surfaces plays a significant role.

Organisation	Cadrenal Therapeutics Inc
Headquarters	822 A1A North, Ponte Vedra, FL, United States, 32082
CEO	Mr. Quang X. Pham
E-voting on shares	Click here to vote

Key Management of Cadrenal Therapeutics Inc

Name	Title
Mr. Jeffrey Cole	Chief Operating Officer
Dr. Matthew Boxer M.B.A., Ph.D.	Executive Vice President of Corporate Development
Mr. Quang X. Pham	Chairman & CEO
Dr. James J. Ferguson FACC, M.D.	Chief Medical Officer

FAQs

What is Cadrenal Therapeutics Inc share price today?

Cadrenal Therapeutics Inc share price today is $4.86 as on April 10, 2026 at 1:24 am IST at the close of the market. Cadrenal Therapeutics Inc share today touched a day high of $5.07 and a low of $4.66.

What is the 52 week high and 52 week low for Cadrenal Therapeutics Inc share?

Cadrenal Therapeutics Inc share touched a 52 week high of $17.5 on April 28, 2025 and a 52 week low of $4.21 on March 30, 2026. Cadrenal Therapeutics Inc stock price today i.e. April 10, 2026 at 1:24 am IST is closed at $4.86,which is 72.23% down from its 52 week high and 15.44% up from its 52 week low.

What is Cadrenal Therapeutics Inc's market capitalisation today?

Cadrenal Therapeutics Inc market capitalisation is $0.00T as on April 10, 2026 at 1:24 am IST.

How to invest in Cadrenal Therapeutics Inc Stock (CVKD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cadrenal Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cadrenal Therapeutics Inc Shares that will get you 0.3086 shares as per Cadrenal Therapeutics Inc share price of $4.86 per share as on April 10, 2026 at 1:24 am IST.

What is the minimum amount required to buy Cadrenal Therapeutics Inc Stock (CVKD) from India?

Indian investors can start investing in Cadrenal Therapeutics Inc (CVKD) shares with as little as ₹92.637 or $1 (as of April 10, 2026 at 12:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.37 in Cadrenal Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 10, 2026 at 12:41 pm IST). Based on Cadrenal Therapeutics Inc share’s latest price of $4.86 as on April 10, 2026 at 1:24 am IST, you will get 2.0576 shares of Cadrenal Therapeutics Inc. Learn more about fractional shares .